• Je něco špatně v tomto záznamu ?

Low-grade oncocytic tumour of kidney (CD117-negative, cytokeratin 7-positive): a distinct entity?

K. Trpkov, SR. Williamson, Y. Gao, P. Martinek, L. Cheng, AR. Sangoi, A. Yilmaz, C. Wang, P. San Miguel Fraile, DM. Perez Montiel, S. Bulimbasić, J. Rogala, O. Hes,

. 2019 ; 75 (2) : 174-184. [pub] 20190321

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc20006516

Grantová podpora
Alberta Public Laboratories
Q39 Charles University Research Fund
FN 00669806 Institutional Research Fund

AIM: To describe a group of distinct low-grade oncocytic renal tumours that demonstrate CD117 negative/cytokeratin (CK) 7-positive immunoprofile. METHODS AND RESULTS: We identified 28 such tumours from four large renal tumour archives. We performed immunohistochemistry for: CK7, CD117, PAX8, CD10, AMACR, e-cadherin, CK20, CA9, AE1/AE3, vimentin, BerEP4, MOC31, CK5/6, p63, HMB45, melan A, CD15 and FH. In 14 cases we performed array CGH, with a successful result in nine cases. Median patient age was 66 years (range 49-78 years) with a male-to-female ratio of 1:1.8. Median tumour size was 3 cm (range 1.1-13.5 cm). All were single tumours, solid and tan-brown, without a syndromic association. On microscopy, all cases showed solid and compact nested growth. There were frequent areas of oedematous stroma with loosely arranged cells. The tumour cells had oncocytic cytoplasm with uniformly round to oval nuclei, but without significant irregularities, and showed only focal perinuclear halos. Negative CD117 and positive CK7 reactivity were present in all cases (in two cases there was focal and very weak CD117 reactivity). Uniform reactivity was found for PAX8, AE1/AE3, e-cadherin, BerEP4 and MOC31. Negative stains included CA9, CK20, vimentin, CK5/6, p63, HMB45, Melan A and CD15. CD10 and AMACR were either negative or focally positive; FH was retained. On array CGH, there were frequent deletions at 19p13.3 (seven of nine), 1p36.33 (five of nine) and 19q13.11 (four of nine); disomic status was found in two of nine cases. On follow-up (mean 31.8 months, range 1-118), all patients were alive with no disease progression. CONCLUSION: Low-grade oncocytic tumours that are CD117-negative/CK7-positive demonstrate consistent and readily recognisable morphology, immunoprofile and indolent behaviour.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20006516
003      
CZ-PrNML
005      
20200522090345.0
007      
ta
008      
200511s2019 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/his.13865 $2 doi
035    __
$a (PubMed)30895640
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Trpkov, Kiril $u University of Calgary and Calgary Laboratory Services, Calgary, AB, Canada.
245    10
$a Low-grade oncocytic tumour of kidney (CD117-negative, cytokeratin 7-positive): a distinct entity? / $c K. Trpkov, SR. Williamson, Y. Gao, P. Martinek, L. Cheng, AR. Sangoi, A. Yilmaz, C. Wang, P. San Miguel Fraile, DM. Perez Montiel, S. Bulimbasić, J. Rogala, O. Hes,
520    9_
$a AIM: To describe a group of distinct low-grade oncocytic renal tumours that demonstrate CD117 negative/cytokeratin (CK) 7-positive immunoprofile. METHODS AND RESULTS: We identified 28 such tumours from four large renal tumour archives. We performed immunohistochemistry for: CK7, CD117, PAX8, CD10, AMACR, e-cadherin, CK20, CA9, AE1/AE3, vimentin, BerEP4, MOC31, CK5/6, p63, HMB45, melan A, CD15 and FH. In 14 cases we performed array CGH, with a successful result in nine cases. Median patient age was 66 years (range 49-78 years) with a male-to-female ratio of 1:1.8. Median tumour size was 3 cm (range 1.1-13.5 cm). All were single tumours, solid and tan-brown, without a syndromic association. On microscopy, all cases showed solid and compact nested growth. There were frequent areas of oedematous stroma with loosely arranged cells. The tumour cells had oncocytic cytoplasm with uniformly round to oval nuclei, but without significant irregularities, and showed only focal perinuclear halos. Negative CD117 and positive CK7 reactivity were present in all cases (in two cases there was focal and very weak CD117 reactivity). Uniform reactivity was found for PAX8, AE1/AE3, e-cadherin, BerEP4 and MOC31. Negative stains included CA9, CK20, vimentin, CK5/6, p63, HMB45, Melan A and CD15. CD10 and AMACR were either negative or focally positive; FH was retained. On array CGH, there were frequent deletions at 19p13.3 (seven of nine), 1p36.33 (five of nine) and 19q13.11 (four of nine); disomic status was found in two of nine cases. On follow-up (mean 31.8 months, range 1-118), all patients were alive with no disease progression. CONCLUSION: Low-grade oncocytic tumours that are CD117-negative/CK7-positive demonstrate consistent and readily recognisable morphology, immunoprofile and indolent behaviour.
650    _2
$a oxyfilní adenom $x patologie $7 D018249
650    _2
$a senioři $7 D000368
650    _2
$a nádorové biomarkery $x analýza $7 D014408
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a imunohistochemie $7 D007150
650    _2
$a keratin-7 $x analýza $x biosyntéza $7 D053552
650    _2
$a nádory ledvin $x patologie $7 D007680
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a protoonkogenní proteiny c-kit $x analýza $x biosyntéza $7 D019009
655    _2
$a časopisecké články $7 D016428
700    1_
$a Williamson, Sean R $u School of Medicine, Henry Ford Health System and Wayne State University, Detroit, MI, USA.
700    1_
$a Gao, Yuan $u University of Calgary and Calgary Laboratory Services, Calgary, AB, Canada.
700    1_
$a Martinek, Petr $u Charles University and University Hospital Pilsen, Pilsen, Czech Republic.
700    1_
$a Cheng, Liang $u Indiana University School of Medicine, Indianapolis, IN, USA.
700    1_
$a Sangoi, Ankur R $u El Camino Hospital, Mountain View, CA, USA.
700    1_
$a Yilmaz, Asli $u University of Calgary and Calgary Laboratory Services, Calgary, AB, Canada.
700    1_
$a Wang, Cheng $u QEII Health Sciences Centre and Dalhousie University, Halifax, NS, Canada.
700    1_
$a San Miguel Fraile, Pilar $u Hospital Álvaro Cunqueiro, Vigo (Pontevedra), Spain.
700    1_
$a Perez Montiel, Delia M $u Institute Nacional de Cancerologia, Mexico City, Mexico.
700    1_
$a Bulimbasić, Stela $u University Hospital Center, Zagreb, Croatia.
700    1_
$a Rogala, Joanna $u Regional Specialist Hospital, Wroclaw, Poland.
700    1_
$a Hes, Ondrej $u Charles University and University Hospital Pilsen, Pilsen, Czech Republic.
773    0_
$w MED00002043 $t Histopathology $x 1365-2559 $g Roč. 75, č. 2 (2019), s. 174-184
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30895640 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200511 $b ABA008
991    __
$a 20200522090343 $b ABA008
999    __
$a ok $b bmc $g 1525374 $s 1096572
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 75 $c 2 $d 174-184 $e 20190321 $i 1365-2559 $m Histopathology $n Histopathology $x MED00002043
GRA    __
$p Alberta Public Laboratories
GRA    __
$a Q39 $p Charles University Research Fund
GRA    __
$a FN 00669806 $p Institutional Research Fund
LZP    __
$a Pubmed-20200511

Najít záznam

Citační ukazatele

Možnosti archivace